Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of NVP-NK4146 in Patients with Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Sponsor: NVP Healthcare
Summary
The purpose of this clinical trial is to exploratively evaluate the efficacy and safety of NVP -NK4146 in improving mild cognitive impairment (MCI) in patients with due to Alzheimer's disease (AD) compared to placebo
Official title: 36-week, Single-center, Randomized, Double-blind, Parallel-design, Placebo-controlled Trial to Determine the Safety and Efficacy of NVP-NK4146 in Patients with Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Key Details
Gender
All
Age Range
60 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-04-01
Completion Date
2026-04-30
Last Updated
2025-01-13
Healthy Volunteers
No
Conditions
Interventions
NVP-NK4146
BID for 36 weeks orally
NVP-NK4146 Placebo
BID for 36 weeks orally